Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium

NCT04447521 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 3600

Last updated 2022-10-27

No results posted yet for this study

Summary

The investigators will conduct a prospective observational study of non-invasive S. pneumoniae infections in Belgium and characterize serotype distributions to evaluate national vaccination programs.

Conditions

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY
  • Merck Sharp & Dohme LLC

    collaborator INDUSTRY
  • Universitaire Ziekenhuizen KU Leuven

    collaborator OTHER
  • Sciensano

    lead OTHER_GOV

Principal Investigators

  • Pieter-Jan Ceyssens, PhD · Sciensano

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-09-01
Primary Completion
2025-05-01
Completion
2025-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04447521 on ClinicalTrials.gov